Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center

Journal of Clinical Microbiology

Volumn 38, Issue 5, 2000, Pages 1791-1796

  Coudron, Philip E ^a   Moland, Ellen S ^b   Thomson, Kenneth S ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOXITIN; CEPHALOSPORINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; ENZYME ASSAY; ESCHERICHIA COLI; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEUS MIRABILIS;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MIRABILIS; NEGIBACTERIA; PROTEUS MIRABILIS;

EID: 0034016951     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.5.1791-1796.2000     Document Type: Article

References (42)

1. Ardanuy, C., J. Linares, M. A. Dominguez, S. Hernandez-Alles, V. J. Benedi, and L. Martinez-Martinez. 1998. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1636-1640.
2. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931.
3. Bauernfeind, A., S. Wagner, R. Jungwirth, I. Schneider, and D. Meyer. 1997. A novel class C β-lactamase (FOX-2) in E. coli conferring resistance to cephamycins. Antimicrob. Agents Chemother. 41:2041-2046.
4. Bauernfeind, A., Y. Chong, and K. Lee. 1998. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after their discovery? Yonsei Med. J. 39:520-525.
5. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
6. Bobrowski, M. M., M. Mathew, P. T. Barth, N. Datta, N. J. Grinter, A. E. Jacob, P. Kontomichalou, J. W. Dale, and J. T. Smith. 1976. Plasmid-determined β-lactamase indistinguishable from the chromosomal β-lactamase of Escherichia coli. J. Bacteriol. 123:149-157.
7. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combinations of ACTT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
8. Bret, L., C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia, and J. Sirot. 1998. Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1110-1114.
9. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
10. Coudron, P. E., E. S. Moland, and C. C. Sanders. 1997. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J. Clin. Microbiol. 35:2593-2597.
11. Gazouli, M., L. S. Tzouvelekis, A. C. Vatopoulos, and E. Tzelepi. 1998. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase, J. Antimicrob. Chemother. 42:419-425.
12. Hernandex-Alles, S., V. J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J. M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.
13. Horii, T., Y. Arakawa, M. Ohta, L. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
14. Jenks, P. J., V. M. Hu, F. Danel, S. Mehtar, and D. M. Livermore. 1995. Plasmid-mediated production of class 1 (AmpC) β-lactamase by two Klebsiella pneumoniae isolates in the UK. J. Antimicrob. Chemother. 35:235-236.
15. Leiza, M. G., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequences and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
16. Liu, P. Y. F., D. Gur, L. M. C. Hall, and D. M. Livermore. 1992. Survey of the prevalence of β-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. J. Antimicrob. Chemother. 30:429-447.
17. Livermore, D. M. β-Lactamases in laboratory and clinical resistance. 1995. Clin. Microbiol. Rev. 8:557-584.
18. Martinez-Martinez, L., A. Pascual, S. Hernandez-Alles, D. Alvarez-Diaz, A. I. Suarez, J. Tran, V. J. Benedi, and G. A. Jacob. 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669-1673.
19. Matsumoto, Y., F. Ikeda, T. Kamimura, Y. Yokota, and Y. Mine. 1988. Novel plasmid-mediated β-lactamase from Escherichia coli that inactivated oxyiminocephalosporins. Antimicrob. Agents Chemother. 32:1243-1246.
20. Morosini, M., M. Negri, B. Shoichet, M. Baquero. F. Baquero, and J. Blazquez. 1998. An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol. Lett. 165:85-90.
21. M'Zali, F. H., J. Heritage, D. M. Gascoyne-Binzi, M. Denton, N. J. Todd, and P. M. Hawkey. 1997. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J. Antimicrob. Chemother. 40:823-831.
22. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing: ninth informational supplement (M100-S9). National Committee for Clinical Laboratory Standards, Wayne, Pa.
25. Nelson, E. C., and B. G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43:957-959.
26. Nicolas-Chanoine, M. H., H. Chardon, J. L. Avril, Y. Cattoen, J. C. Croix, H. Dabernat, J. Etienne, T. Fosse, J. C. Ghnassia, E. Lecaillon, A. Marmonier, M. Roussel-Delvallez, J. C. Soussy, A. Trevoux, and J. Sirot. 1997. Susceptibility of Enterobacteriaceae to beta-lactams and fluoroquinolones: a French multicentre study. Clin. Microbiol. Infect. 3(Suppl. 2):74-75.
27. Normark, S., T. Grunstrom, and S. Bergstrom. 1980. Susceptibility to penicillins and cephalosporins in β-lactamase producing strains of E. coli and relative amount of β-lactamase produced from these strains. Scand. J. Infect. Dis. 25:23-29.
28. Pangon, B., C. Bizet, A. Bure, F. Pichon, A. Philippon, B. Regnier, and L. Gutmann. 1989. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase. J. Infect. Dis. 159:1005-1006.
29. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
30. Payne, D. J., N. Woodford, and S. G. B. Amyes. 1992. Characterization of the plasmid-mediated β-lactamase BIL-1. J. Antimicrob. Chemother. 30:119-127.
31. Pornull, K. J., G. Rodrigo, and K. Dornbusch. 1994. Production of a plasmid-mediated AmpC-like β-lactamase by a Klebsiella pneumoniae septicemia isolate. J. Antimicrob. Chemother. 34:943-954.
32. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
33. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
34. Tenover, F. C., M. J. Mohammed, T. S. Gorton, and Z. F. Dembek. 1999. Detection and reporting of organisms producing extended-spectrum β-lactamases: survey of laboratories in Connecticut. J. Clin. Microbiol. 37:4065-4070.
35. Thomson, K. S., A. M. Prevan, and C. C. Sanders. 1996. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new B-lactam antibiotics, p. 151-163. In J. S. Remington and M. N. Swartz (ed.). Current clinical topics in infectious diseases, vol. 16. Blackwell Science, Inc., Cambridge, Mass.
36. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.
37. Thomson, K. S., C. C. Sanders, and E. S. Moland. 1999. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Antimicrob. Agents Chemother. 43:1393-1400.
38. Tzouvelekis, L. S., A. C. Vatopoulos, G. Katsanis, and E. Tzelepi. 1999. Rare case of failure by an automated system to detect extended-spectrum β-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate. J. Clin. Microbiol. 37:2388.
39. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645-654.
40. Tzouvelekis, L. S., M. Gazouli, E. E. Prinarakis, E. Tzelepi, and N. J. Legakis. 1997. Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against β-lactamases that belong to groups 1, 2b. and 2be. Antimicrob. Agents Chemother. 41:475-477.
41. Vercauteren, E., P. Descheemaeker, M. Ieven, C. C. Sanders, and H. Goossens. 1997. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol. 35:2191-2197.
42. Verdet, C, G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase, in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235-240.